Claims for Patent: 8,702,654

Summary for Patent: 8,702,654

Title:	Treatment of carpal tunnel syndrome by injection of the flexor retinaculum
Abstract:	An apparatus and method for identifying the flexor retinaculum of the carpal tunnel, injecting an effective amount of an agent into at least a portion of flexor retinaculum or tissue adjacent thereto, wherein the agent is configured to weaken the flexor retinaculum. The system may further include means for increasing the tensile stress in the flexor retinaculum post-injection using hand exercises, thereby weakening its structural integrity and decreasing the pressure within the carpal tunnel that impairs median nerve function.
Inventor(s):	Agee; John M. (Cameron Park, CA), Goss; Ben C. (Athens, GA), King; Francis C. (Sacramento, CA), Woodhouse; Jeffrey (Sacramento, CA)
Assignee:	Agee; John M. (Sacramento, CA)
Application Number:	12/732,047
Patent Claims:	1. A system for treating a patient's hand, comprising: a needle guide; an injection needle; the needle guide comprising a guide hole configured for receiving the injection needle; a clamp coupled to the needle guide; wherein the clamp comprises a reference surface for positioning at a palm of the patient's hand; wherein the needle guide is slideably coupled to the clamp such that the needle guide may be adjusted with respect to the reference surface; an imaging device configured for real-time imaging the flexor retinaculum with respect to surrounding tissue during injection; wherein the clamp is configured to house the imaging device; wherein the imaging device comprises an imaging surface; wherein the imaging surface is substantially parallel to a longitudinal axis of the guide hole of the needle guide; and an agent configured for delivery within said injection needle to a tissue region associated with the flexor retinaculum of the patient. 2. A system as recited in claim 1, wherein a longitudinal axis of the guide hole is substantially parallel to the reference surface. 3. A system as recited in claim 1, wherein the imaging device is pivotably attached to the clamp to allow for the imaging device to be oriented with respect to the clamp to obtain transverse and longitudinal images of the flexor retinaculum. 4. A system as recited in claim 1, wherein the needle guide is configured to be adjusted in a palmar-dorsal direction while the longitudinal axis of the guide hole remains substantially parallel to the imaging surface. 5. A system as recited in claim 1, wherein the clamp and needle guide comprise an indicator configured to indicate a depth of needle insertion with respect to the reference surface. 6. A system as recited in claim 1, further comprising: a guide tube disposed within the guide hole; the guide tube configured to be inserted into the hand adjacent the flexor retinaculum; wherein the guide tube comprises a central channel sized to accommodate delivery of an instrument to the tissue region. 7. A system as recited in claim 6, further comprising: a pressure sensor sized to be received within said guide tube to be delivered to the tissue region; wherein the pressure sensor is configured to measure pressure at a location in said tissue region. 8. A system as recited in claim 6, further comprising: a cutting probe sized to be received within said guide tube to be delivered to the tissue region; wherein the cutting probe is configured to cut tissue associated with the flexor retinaculum. 9. A system as recited in claim 1, further comprising: a linkage attached to the clamp; wherein the linkage is configured to couple to the patient's hand; and wherein the linkage comprises a first joint that allows rotation of the clamp with respect to the hand. 10. A system as recited in claim 9, wherein the clamp is configured to rotate about the first joint in a palmar-dorsal direction with respect to the patient's hand. 11. A system as recited in claim 10, the linkage further comprising: a second joint oriented perpendicular to the first joint; wherein the clamp is configured to rotate about the second joint in a radial-ulnar direction with respect to the patient's hand. 12. A system as recited in claim 11, the linkage further comprising: a third joint; wherein the clamp is configured to rotate about the third joint in an internal-external direction with respect to the patient's hand. 13. A system as recited in claim 9, wherein the linkage is configured to allow proximal to distal translation of the clamp with respect to the patient's hand. 14. A system as recited in claim 1, wherein said agent is formulated to weaken the structural integrity of the flexor retinaculum. 15. A system for treating a patient's hand, comprising: a needle guide; an injection needle; the needle guide comprising a guide hole configured for receiving the injection needle; a clamp coupled to the needle guide; wherein the clamp comprises a reference surface for positioning at a palm of the patient's hand; wherein the needle guide is slideably coupled to the clamp such that the needle guide may be adjusted with respect to the reference surface; a linkage attached to the clamp; wherein the linkage is configured to couple to the patient's hand; and wherein the linkage comprises a first joint that allows rotation of the clamp with respect to the hand; wherein the clamp is configured to rotate about the first joint in a palmar-dorsal direction with respect to the patient's hand; and an agent configured for delivery within said injection needle to a tissue region associated with the flexor retinaculum of the patient. 16. A system as recited in claim 15, wherein said agent is formulated to facilitate rupture of collagen fibers within the flexor retinaculum. 17. A system as recited in claim 15, wherein said agent is formulated to facilitate lengthening of collagen fibers within the flexor retinaculum. 18. A system as recited in claim 15, wherein said agent is formulated to facilitate failure of collagen fibers within the flexor retinaculum. 19. A system as recited in claim 15, wherein said agent comprises one or more doses of collagenase. 20. A system as recited in claim 19, wherein said agent comprises an injectable form of clostridium histolyticum. 21. A system as recited in claim 15, further comprising an imaging device configured for real-time imaging the flexor retinaculum with respect to surrounding tissue during injection; wherein the clamp is configured to house the imaging device. 22. A system as recited in claim 21, wherein the imaging device is pivotably attached to the clamp to allow for the imaging device to be oriented with respect to the clamp to obtain transverse and longitudinal images of the carpal flexor retinaculum. 23. A system as recited in claim 21, wherein the imaging device uses ultrasound. 24. A system as recited in claim 15, the linkage further comprising: a second joint oriented perpendicular to the first joint; wherein the clamp is configured to rotate about the second joint in a radial-ulnar direction with respect to the patient's hand. 25. A system as recited in claim 24, the linkage further comprising: a third joint oriented perpendicular to the first joint and second joint; wherein the clamp is configured to rotate about the third joint in an internal-external direction with respect to the patient's hand. 26. A system as recited in claim 15, wherein the linkage is configured to allow proximal to distal translation of the clamp with respect to the patient's hand. 27. A system as recited in claim 15, wherein said agent is formulated to weaken the structural integrity of the flexor retinaculum.

Details for Patent 8,702,654

Applicant	Tradename	Biologic Ingredient	Dosage Form	BLA	Approval Date	Patent No.	Expiredate
Smith & Nephew, Inc.	SANTYL	collagenase	Ointment	101995	06/04/1965		2029-03-25